“…The mouse bioassay (MBA), which has been used for a long time for CTXs’ detection, has become obsolete owing to its insufficient detection capability and ethical concerns [ 31 ]. Therefore, alternative methods, such as liquid chromatography with tandem mass spectrometry (LC-MS/MS) [ 32 , 33 ], capillary LC-HRMS [ 25 ], sandwich enzyme-linked immunosorbent assay (ELISA) [ 34 ], receptor binding assay (RBA) [ 32 , 35 , 36 , 37 ], neuroblastoma cell-based assay (N2a assay) [ 32 , 36 , 38 , 39 ], and even portable biosensors [ 40 , 41 , 42 , 43 ] have been developed in recent years. The RBA and N2a assays, which respond indistinguishably to all CTXs, complement LC-MS/MS and sandwich ELISA, which quantify the congeners individually.…”